切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (06) : 367 -370. doi: 10.3877/cma.j.issn.2095-3232.2014.06.009

所属专题: 文献

临床研究

AFP阳性肝内胆管细胞癌患者的临床特征及其预后影响因素
王庆亮1, 许世磊1, 张鹏1, 黄河1, 姚志成1, 杨培生1, 刘波1,()   
  1. 1. 510530 广州,中山大学附属第三医院普通外科
  • 收稿日期:2014-08-02 出版日期:2014-12-10
  • 通信作者: 刘波
  • 基金资助:
    广东省科技计划项目(2012B31800031)

Clinical characteristics and prognostic factors of intrahepatic cholangiocarcinoma with positive AFP

Qingliang Wang1, Shilei Xu1, Peng Zhang1, He Huang1, Zhicheng Yao1, Peisheng Yang1, Bo Liu1,()   

  1. 1. Department of General Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510530, China
  • Received:2014-08-02 Published:2014-12-10
  • Corresponding author: Bo Liu
  • About author:
    Corresponding author: Liu Bo, Email:
引用本文:

王庆亮, 许世磊, 张鹏, 黄河, 姚志成, 杨培生, 刘波. AFP阳性肝内胆管细胞癌患者的临床特征及其预后影响因素[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(06): 367-370.

Qingliang Wang, Shilei Xu, Peng Zhang, He Huang, Zhicheng Yao, Peisheng Yang, Bo Liu. Clinical characteristics and prognostic factors of intrahepatic cholangiocarcinoma with positive AFP[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(06): 367-370.

目的

探讨AFP阳性肝内胆管细胞癌(ICC)患者的临床特点及预后影响因素。

方法

回顾性研究2004年9月至2013年12月在中山大学附属第三医院接受诊治的57例ICC患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。其中男34例,女23例;平均年龄(52±13)岁。根据入院后血清AFP检测结果将患者分为AFP阳性组(16例)和AFP阴性组(41例)。比较两组患者的年龄、性别、HBsAg,合并肝硬化、胆道病变,术前糖链抗原19-9(CA19-9)、手术方式、淋巴结转移、组织学分化程度等临床病理学参数。对患者进行随访,记录两组生存情况。临床病理学参数比较采用t检验、χ2检验或Fisher确切概率法,生存预后影响因素分析采用Log-rank检验和Cox比例风险回归模型多因素分析。

结果

AFP阳性组中男性占94% (15/16),明显高于AFP阴性组的46% (19/41)(χ2=10.747,P<0.05)。AFP阳性组合并肝硬化患者占88% (14/16),明显高于AFP阴性组的37% (15/41) (χ2=11.937,P<0.05)。AFP阳性组患者无合并胆道病变,AFP阴性组12例合并胆道病变,两组比较差异有统计学意义(P<0.05)。手术方式为AFP阳性组患者预后的独立危险因素,根治性切除患者预后好(RR=26.813,P<0.05)。

结论

AFP阳性ICC患者多合并肝硬化,较少合并胆道病变。手术方式为影响患者预后的独立危险因素,根治性切除是改善AFP阳性ICC患者预后的有效手段。

Objective

To investigate the clinical characteristics and prognostic factors in intrahepatic cholangiocarcinoma (ICC) patients with positive alpha-fetoprotein (AFP).

Methods

Clinical data of 57 patients with ICC in the Third Affiliated Hospital of Sun Yat-sen University from September 2004 to December 2013 were analyzed retrospectively. The informed consents of all patients were obtained and the ethical committee approval was received. There were 34 males and 23 females with an average age of (52±13) years old. According to serum AFP test result after admission in hospital, the patients were divided into AFP positive group (n=16) and AFP negative group (n=41). The difference of clinicopathological factors between two groups such as age, gender, hepatitis B surface antigen (HBsAg), liver cirrhosis, biliary lesions, preoperative carbohydrate antigen 19-9 (CA19-9), surgical procedure, metastastic lymph nodes, histological differentiation degree were compared by t-test , Chi-square test or Fisher's exact probability test. The patients were followed up and the survival of two groups was recorded. Prognostic factors analysis was conducted by Log-rank test and Cox proportional hazards regression model.

Results

Male patients accounted for 94% (15/16) in AFP positive group, which was significantly higher than that in AFP negative group [46% (19/41)] (χ2=10.747, P<0.05). Patients complicated with liver cirrhosis accounted for 88% (14/16) , which was significantly higher than that in AFP negative group [37% (15/41)] (χ2=11.937, P<0.05). No patients were complicated with biliary lesions in AFP positive group but in AFP negative group, 12 cases were complicated with biliary lesions, where significant difference was observed between two groups (P<0.05). Surgical procedure was the independent risk factor for patients in AFP positive group. Patients undergoing radical resection had better prognosis (RR=26.813, P<0.05).

Conclusions

ICC patients with positive AFP are mostly complicated with liver cirrhosis but a low incidence of biliary lesions. Surgical procedure is the independent risk factor for the prognosis. Radical resection is an effective way to improve the prognosis of ICC patients with positive AFP.

表1 AFP阳性组与AFP阴性组患者的临床病理学参数的比较(例)
图1 AFP阳性组与AFP阴性组肝内胆管细胞癌患者的Kaplan-Meier生存曲线
[1]
Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma[J]. World J Gastroenterol, 2010, 16(4):418-424.
[2]
Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135(8):1073-1080.
[3]
Zhou H, Wang H, Zhou D, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis[J]. Eur J Cancer, 2010, 46(6):1056-1061.
[4]
Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocarcinoma[J]. Surg Clin North Am, 2010, 90(4):817-837.
[5]
Yamamoto K, Imamura H, Matsuyama Y, et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J]. J Gastroenterol, 2010, 45(12):1272-1282.
[6]
Forner A, Reig M, Bruix J. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star[J]. Gastroenterology, 2009, 137(1):26-29.
[7]
Shen WF, Zhong W, Xu F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma[J]. World J Gastroenterol, 2009, 15(47):5976-5982.
[8]
Yamamoto M, Ariizumi S, Otsubo T, et al. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma[J]. J Surg Oncol, 2004, 87(2):80-83, 83-84.
[9]
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma[J]. Hepatology, 2011, 54(1):173-184.
[10]
Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2012, 57(1):69-76.
[11]
Malaguarnera G, Paladina I, Giordano M, et al. Serum markers of intrahepatic cholangiocarcinoma[J]. Dis Markers, 2013, 34(4):219-228.
[12]
Zhou YM, Yang JM, Li B, et al. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein[J]. World J Gastroenterol, 2008, 14(14):2251-2254.
[13]
Witjes CD, Polak WG, Verhoef C, et al. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers[J]. Dig Surg, 2012, 29(6):522-528.
[14]
Gadelhak NA, Gadelhak SA, El-Morsi DA, et al. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma[J]. Hepatogastroenterology, 2009, 56(94/95):1417-1424.
[15]
de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol, 2011, 29(23):3140-3145.
[16]
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(11):1917-1928.
[17]
Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival[J]. Ann Surg Oncol, 2009, 16(11):3048-3056.
[18]
Li DY, Zhang HB, Yang N, et al. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series[J]. World J Gastroenterol, 2013, 19(47):9084-9091.
[19]
Morine Y, Shimada M, Utsunomiya T, et al. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma[J]. Surg Today, 2012, 42(2):147-151.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[3] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[9] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[10] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[13] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[14] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[15] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
阅读次数
全文


摘要